Trials / Conditions / Refractory Childhood Acute Lymphoblastic Leukemia
Refractory Childhood Acute Lymphoblastic Leukemia
5 registered clinical trials studyying Refractory Childhood Acute Lymphoblastic Leukemia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling NCT05857969 | Florida International University | Phase 1 |
| Completed | Ex Vivo Drug Sensitivity Testing and Mutation Profiling NCT03860376 | Florida International University | — |
| Terminated | Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acut NCT02819804 | Northwestern University | Phase 1 |
| Completed | CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) NCT03289455 | Autolus Limited | Phase 1 / Phase 2 |
| Completed | Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in NCT01858740 | Fred Hutchinson Cancer Center | Phase 2 |